For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

New Hormone Therapies Aim to Improve Obesity Treatment Outcomes

Aug 31, 2026
New Hormone Therapies Aim to Improve Obesity Treatment Outcomes

The landscape of obesity treatment is shifting with the introduction of new hormone therapies that aim to improve both weight loss outcomes and patient tolerability. Semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) have already set a high bar for weight loss, achieving results comparable to bariatric surgery. However, the focus is now expanding beyond just weight loss to include factors such as muscle preservation and individualized treatment strategies. Dr. Brian Wojeck, an endocrinologist at Yale Medicine, emphasizes that new therapies must either enhance effectiveness or improve tolerability to stand out in a competitive market.

Among the innovative treatments being studied are those that combine multiple hormones into a single medication. Tirzepatide exemplifies this approach by integrating glucagon-like peptide-1 (GLP-1), which promotes feelings of fullness, with glucose-dependent insulinotropic polypeptide (GIP), which plays a role in metabolism and blood sugar regulation. This dual-action strategy has laid the groundwork for the idea that combining hormones could yield better results in obesity management.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

One of the most promising experimental drugs is retatrutide, which targets three hormones—GLP-1, GIP, and glucagon—simultaneously. Although it has not yet received approval from the U.S. Food and Drug Administration (FDA), clinical trials have shown that retatrutide can produce weight loss results that approach those typically seen with bariatric surgery. However, Dr. John Morton, chief of Yale Medicine Bariatric and Minimally Invasive Surgery, cautions that while greater weight loss is beneficial, tolerability and long-term adherence to treatment are equally important.

Another hormone under investigation is amylin, which is released alongside insulin and contributes to feelings of fullness while helping to regulate blood sugar levels. Early research indicates that amylin-based therapies could lead to significant weight loss with fewer gastrointestinal side effects compared to existing medications. Dr. Morton notes that although synthetic amylin was approved for diabetes treatment in 2005, it did not achieve widespread use due to the need for frequent injections. Newer formulations are being developed to enhance patient compliance.

In clinical studies, amylin therapies have shown potential for weight loss of about 15% of body weight, which, while less than the nearly 30% seen with some triple-hormone medications, can still yield substantial health benefits, including improvements in high blood sugar and blood pressure. Researchers are also investigating the possibility that amylin could positively impact bone health while facilitating weight loss, although further studies are necessary to confirm these findings.

Despite the encouraging early results, Dr. Wojeck highlights the need for larger studies and real-world data to fully understand how these emerging therapies will perform outside clinical trial settings. Gastrointestinal side effects, such as nausea and digestive discomfort, remain common reasons for patients discontinuing treatment. Additionally, researchers are examining how significant weight loss affects muscle mass and bone density, with the goal of developing therapies that can better protect these critical aspects of health.

For obesity specialists, the focus is shifting from merely achieving weight loss to ensuring that treatments are well-tolerated and lead to improved long-term health outcomes. Dr. Morton asserts that the goal of these new medications should not solely be weight loss but rather tolerability and overall health improvement. He and Dr. Wojeck acknowledge that significant weight loss can sometimes result in muscle mass loss and reduced bone density, but when combined with proper nutrition and exercise, many patients can experience enhanced mobility and functioning.

A significant challenge in obesity treatment remains the variability in patient responses to medications. Dr. Morton points out that approximately 10% of clinical trial participants lose less than 5% of their body weight, indicating a need for a deeper understanding of the biological underpinnings of obesity. Dr. Wojeck observes similar patterns in his practice, noting that some patients who do not respond well to newer therapies may find success with older treatments.

Currently, selecting an appropriate treatment often involves a degree of trial and error, as the medical community has not yet reached a point where they can predict which medication will work best for each individual. However, both doctors are optimistic about the future, anticipating a diverse range of drugs tailored to meet the unique biological and health needs of patients.

Most of the therapies discussed, including retatrutide and new amylin-based drugs, are still in clinical trials and not available for general use. Patients currently on GLP-1 medications are encouraged to consult their healthcare providers for guidance on their treatment options as research continues to evolve in the field of obesity management.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)